Video Experimental Relacionado
Updated: May 6, 2026
07:48
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
12.8K
Un enfoque integrado para descubrir los impulsores del cáncer
Uri David Akavia1, Oren Litvin, Jessica Kim
1Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
Cell
|December 7, 2010
Resumen
Este estudio introduce un marco computacional para identificar las alteraciones genéticas que impulsan el cáncer mediante la integración del número de copias y los datos de expresión génica. El enfoque identificó con éxito los principales impulsores del melanoma y reveló nuevas dependencias, lo que sugiere nuevos objetivos terapéuticos.
Área de la Ciencia:
- La genómica es la genómica.
- Biología computacional Biología computacional.
- Investigación del cáncer Investigación del cáncer.
Sus antecedentes:
- Los genomas del cáncer exhiben diversas aberraciones genéticas con un significado funcional poco claro.
- La identificación de los factores clave de la progresión tumoral es crucial para el desarrollo terapéutico.
Objetivo del estudio:
- Desarrollar y validar un marco computacional para detectar aberraciones genéticas que promueven el cáncer.
- Identificar nuevas dependencias tumorales y posibles objetivos terapéuticos en el melanoma.
Principales métodos:
- Análisis integrado del número de copias cromosómicas y datos de expresión génica.
- Aplicación de un marco computacional utilizando enfoques bayesianos.
- Validación empírica de las dependencias predictivas del tumor.
Principales resultados:
- El marco identificó con éxito los factores impulsores conocidos del melanoma.
- Se predijeron y confirmaron empíricamente dos nuevas dependencias tumorales: TBC1D16 y RAB27A.
- Destacó el papel de la desregulación del tráfico de proteínas en la proliferación del melanoma.
Conclusiones:
- Los enfoques computacionales integrales pueden identificar con eficacia los factores biológicamente significativos del cáncer.
- Las dependencias identificadas, TBC1D16 y RAB27A, representan objetivos terapéuticos potenciales en el melanoma.
- El tráfico anormal de proteínas está implicado en la progresión del melanoma.
Videos de Conceptos Relacionados
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
02:59Cancer Prevention
6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.5K
02:57Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
01:21Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870